Obesity-related cardiac and vascular structural alterations: Beyond blood pressure overload

Journal of Hypertension

Volumn 27, Issue 9, 2009, Pages 1750-1752

  Grassi, Guido ^a   Diez, Javier ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BODY MASS; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; HYPERTENSION; NOTE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE;

EID: 73249151569     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328330e8ae     Document Type: Note

References (17)

1. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. W Engl J Med 2002; 347:305-313.
2. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al., INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 2005; 366:1640-1649. (Pubitemid 41552419)
3. Postorino M, Marino C, Tripepi G, Zoccali C, CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group. Abdominal obesity and allcause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53:1265-1272.
4. Norton GR, Majane OH, Libhaber E, Maseko MJ, Makaula S, Libhaber C, et al. The relationship between blood pressure and left ventricuiar mass index depends on an excess adiposity. J Hypertens 2009; 27:1873-1883.
5. Majane OH, Norton GR, Maseko MJ, Makaula S, Crowther N, Paiker J, et al. The association of waist circumference with ambulatory blood pressure is independent of alternative adiposity indices. J Hypertens 2007; 25:1798-1806. (Pubitemid 47356619)
6. Messerli FH, Ventura HO, Reisin E, Dreslinski GR, Dunn FG, MacPhee AA, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 1982; 66:55-60. (Pubitemid 12069957)
7. Messerli FH. Cardiopathy of obesity: a not-so-Victorian disease. W Engl J Med 1986; 314:378-380.
8. Maneia G, Scopelliti F, Grassi G. Hypertension and the heart. Semin Cardiothorac Vase Anesth 2006; 10:198-202.
9. Diez J. Towards a new paradigm about hypertensive heart disease. Med Clin North Am 2009; 93:637-645.
10. Diez J, Laviades C, Martinez E, Gil MJ, Monreal I, Fernández J, et al. Insulinlike growth factor binding proteins in arterial hypertension: relationship to left ventricular hypertrophy. J Hypertens 1995; 13:349-355.
11. Maneia G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Grassi G. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease. J Hypertens 2006; 24:S51-S56. (Pubitemid 44336824)
12. Natal C, Fortuño MA, Restítuto P, Bazán A, Colina I, Diez J, et al. Cardiotrophin-1 is expressed in the adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Heart Circ Physiol 2008; 294:E52-E60.
13. López B, González A, Lasarte JJ, Sarobe P, Borras F, Diaz A, et al. Is plasma cardiotrophin-1 a marker of hypertensive heart disease. J Hypertens 2005; 23:625-632. (Pubitemid 40684722)
14. López B, Castellano JM, González A, Barba J, Diez J. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension. Hypertension 2007; 50:977-983. (Pubitemid 350287544)
15. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] study). Circulation 2001; 104:1385-1392. (Pubitemid 32880151)
16. Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella ML, Dell'Oro R, et al. Heart rate as marker of sympathetic activity. J Hypertens 1998; 16:1635-1639. (Pubitemid 28515490)
17. Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Maneia G, et al., European Society of Hypertension. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006; 24:603-610.